Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

[Effectiveness of mesoglycan in the prevention of cerebral ischemia].

Bettini R, Maino C, Gorini M.

Clin Ter. 2003 Jan-Feb;154(1):13-6. Italian.

PMID:
12854278
2.

Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.

Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F; Mesoglycan Intermittent Claudication Group.

Thromb Haemost. 2001 Nov;86(5):1181-7.

PMID:
11816704
3.

[Effectiveness of mesoglycan therapy in patients with ischemia of the lower limbs. Preliminary results of a new therapeutic protocol].

Raso AM, Maggio D, Trogolo M, Rispoli P, Sandrone N, Pezzuto D, Bellan A, Melloni CD.

Minerva Cardioangiol. 1997 Jul-Aug;45(7-8):383-92. Italian.

PMID:
9463174
4.

Mesoglycan in treatment of patients with cerebral ischemia: effects on hemorheologic and hematochemical parameters.

Vecchio F, Zanchin G, Maggioni F, Santambrogio C, De Zanche L.

Acta Neurol (Napoli). 1993 Dec;15(6):449-56.

PMID:
8160557
5.

A new low molecular weight heparan sulphate antagonizes kappa-carrageenan-induced thrombosis in rats.

Gervasi GB, Bartoli C, Carpita G.

Pharmacol Res. 1991 Jul;24(1):59-63.

PMID:
1658763
6.

[Mesoglycan in acute focal cerebral ischemia].

Cazzato G, Zorzon M, Masé G, Antonutti L, Iona LG.

Riv Neurol. 1989 May-Jun;59(3):121-6. Italian.

PMID:
2531910
7.

Open trial of mesoglycan in the treatment of cerebrovascular ischemic disease.

Mansi D, Sinisi L, De Michele G, Di Geronimo G, Palma V, Brescia Morra V, Coppola N, Buscaino GA.

Acta Neurol (Napoli). 1988 Apr;10(2):108-12. No abstract available.

PMID:
2969172
8.

Effects of mesoglycan sulfate on the arterial elastic module.

Andreozzi GM, Signorelli S, Lo Duca S, Minacapelli C, Amico-Roxas MT, Minardo G, Cacciaguerra G.

Angiology. 1987 Aug;38(8):593-600.

PMID:
2957940

Supplemental Content

Loading ...
Support Center